Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Pharmacokinetic”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05425719
What this trial is testing

Pharmacokinetics and Safety of MB-102 (Relmapirazin) and the MediBeacon Transdermal GFR Measurement System in Evaluation of Kidney Function in Normal and Renal Compromised Subjects

Who this might be right for
Chronic Kidney Disease
MediBeacon 249
Testing effectiveness (Phase 2)Study completedNCT01970865
What this trial is testing

PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

Who this might be right for
ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC
Pfizer 364
Early research (Phase 1)Ended earlyNCT04622072
What this trial is testing

XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sihuan Pharmaceutical Holdings Group Ltd. 21
Early research (Phase 1)UnknownNCT06373094
What this trial is testing

A Single Dose Escalation Study of HHT201 in Healthy Subjects

Who this might be right for
Alzheimer Disease
Shanghai Synergy Pharmaceutical Sciences Co., Ltd. 64
Early research (Phase 1)Study completedNCT01537172
What this trial is testing

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Who this might be right for
Healthy Adult Subjects
Ono Pharmaceutical Co., Ltd. 80
Early research (Phase 1)Study completedNCT04081857
What this trial is testing

Evaluate the Pharmacokinetics and Safety of HCP1704 in Healthy Subjects

Who this might be right for
Health, Subjective
Hanmi Pharmaceutical Company Limited 48
Early research (Phase 1)Study completedNCT01429675
What this trial is testing

Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult Volunteers

Who this might be right for
Healthy
Alvogen Korea 105
Early research (Phase 1)Study completedNCT02069821
What this trial is testing

Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

Who this might be right for
Healthy
HK inno.N Corporation 56
Large-scale testing (Phase 3)Study completedNCT01072149
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic (PK), and Pharmacodynamic (PD) Profiles of 3 Doses of Fluticasone Furoate (FF)/GW642444 Inhalation Powder at the End of a 28-day Treatment Period in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Compared to Placebo

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 54
Early research (Phase 1)Looking for participantsNCT07800936
What this trial is testing

HP007 Monotherapy for Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumors
Parr Biotechnology (Hebei) Co., Ltd. 44
Testing effectiveness (Phase 2)Study completedNCT04175847
What this trial is testing

A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 198
Large-scale testing (Phase 3)Active Not RecruitingNCT06505837
What this trial is testing

JS001sc or JS001 Plus Chemotherapy is Indicated for Relapsed or Metastatic First-Line Non-Squamous Non Small Cell Lung Cancer（NSCLC）

Who this might be right for
Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
Shanghai Junshi Bioscience Co., Ltd. 395
Early research (Phase 1)Study completedNCT03056209
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of KL1333 in Healthy Male Volunteers

Who this might be right for
MELAS SyndromeMitochondrial Respiratory Chain Deficiencies
Yungjin Pharm. Co., Ltd. 60
Early research (Phase 1)Not Yet RecruitingNCT07794111
What this trial is testing

A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.

Who this might be right for
Obesity / Overweight
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 108
Early research (Phase 1)Not Yet RecruitingNCT07798284
What this trial is testing

A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention

Who this might be right for
Overweight/Obesity
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT04213807
What this trial is testing

A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Anthos Therapeutics, Inc. 28
Early research (Phase 1)Ended earlyNCT02432664
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male Volunteers

Who this might be right for
Healthy
Orion Corporation, Orion Pharma 85
Early research (Phase 1)Study completedNCT01894399
What this trial is testing

Study to Evaluate a Pharmacokinetic of HM61713 in Healthy Male Subjects

Who this might be right for
Healthy Volunteers
Hanmi Pharmaceutical Company Limited 59
Early research (Phase 1)UnknownNCT06462716
What this trial is testing

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Chengdu Baiyu Pharmaceutical Co., Ltd. 36
Early research (Phase 1)Active Not RecruitingNCT03459170
What this trial is testing

Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant

Who this might be right for
Hematologic Malignancy
Bellicum Pharmaceuticals 15
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation